Sanofi taps outcomes exec for new C-level job as 'patient officer'

Last week, Johnson & Johnson ($JNJ) chalked up a Big Pharma first by hiring a chief design officer. This week, the groundbreaker is Sanofi ($SNY). The job? Chief Patient Officer. Report

Suggested Articles

Researchers scoured the database where pharma companies disclose payments made to physicians and discovered a troubling trend.

Just a few months after playing a pivotal role in Sanofi’s Bioverativ buy, Alex Denner has set his sights on Ironwood.

Clovis' new approval will boost Rubraca in recurrent ovarian cancer, but because of its competitors' head start, the race will be tough.